🔎 Trials Near Me

Hjem › Lupus › Illinois › Chicago

Lupus kliniske forsøg i Chicago, IL

8 studier for Lupus søger deltagere på steder i og omkring Chicago (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

RekruttererFase 3
  • Sl0044 50699, Chicago
Alder 16 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06617325

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

RekruttererFase 3
  • Research Site, Chicago
  • Research Site, Chicago
Alder 5 til 17 · Alle køn · Opdateret 30. sep. 2026 · NCT05835310

A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis

RekruttererFase 2
  • University of Chicago, Chicago
Alder 16 til 70 · Alle køn · Opdateret 17. sep. 2026 · NCT07328581

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

RekruttererFase 1/2
  • Research Site, Chicago
Alder 18 til 70 · Alle køn · Opdateret 10. sep. 2026 · NCT06897930

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

RekruttererFase 1
  • The University of Chicago Medical Center, Chicago
Alder 18 til 74 · Alle køn · Opdateret 10. sep. 2026 · NCT07085104

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

RekruttererFase 1
  • Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago
Alder 18 til 70 · Alle køn · Opdateret 28. aug. 2026 · NCT06925542

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

RekruttererFase 1/2
  • Northwestern Memorial Hospital, Chicago
  • The University of Chicago Medical Center, Chicago
Alder 18 til 65 · Alle køn · Opdateret 26. aug. 2026 · NCT06121297

Lupus Landmark Study: A Prospective Registry and Biorepository

RekruttererObservationsstudie
  • University of Chicago, Chicago
Alder 18 til 110 · Alle køn · Opdateret 15. apr. 2026 · NCT05934149

Lupus forsøg i andre byer

Andre studier i Chicago

Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.